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Abstract Proteins are targets of reactive species and detection 
of oxidatively modified proteins is often used as an index of 
oxidative stress. Peroxynitrite is a strong oxidant formed by 
reaction of nitric oxide with superoxide. Using fatty acid-free 
bovine serum albumin as a model we examined peroxynitrite- 
mediated protein modifications. The reaction of protein with per- 
oxynitrite resulted in the oxidation of tryptophan and cysteine, 
in the nitration of tyrosine, in the formation of dityrosine, in the 
production of 2,4 dinitrophenylhydrazine-reactive carbonyis and 
in protein fragmentation. The formation of 3-nitrotyrosine repre- 
sents a specific peroxynitrite-mediated protein modification that 
is different from modifications mediated by reactive oxygen 
species. 
Key words." Nitrotyrosine; Dityrosine; Protein carbonyl; 
Tryptophan oxidation; Protein fragmentation 
1. Introduction 
Peroxynitrite is formed by the reaction between two free 
radicals, nitric oxide and superoxide: 
• NO + O~ --+ ONO0-  
Peroxynitrite is not a free radical because the unpaired elec- 
trons of nitric oxide and superoxide are combined to form a 
new bond in peroxynitrite [1]. The second order rate constant 
of  the reaction between itric oxide and superoxide is 6.7 x 109 
M- l . s  ~ [2]. The rate of the nitric oxide reaction with superox- 
ide is approximately thirty times faster than the reaction of 
nitric oxide with oxyhemoglobin and three times faster than the 
reaction of superoxide with superoxide dismutase. Stimulated 
macrophages, neutrophils and endothelial cells have been 
shown to generate peroxynitrite [3-5] and recent data has pro- 
vided evidence for in vivo formation of peroxynitrite in human 
atherosclerotic coronary vessels, in human acute lung injury 
and in chronic inflammation [6-9]. 
Peroxynitrite or its reactive intermediates can be toxic by 
reacting with several biological molecules. Peroxynitrite will 
oxidize unsaturated fatty acids in the absence of a metal catalyst 
to form thiobarbituric acid reactive substances and conjugated 
dienes [10], and to oxidize low molecular mass antioxidant 
molecules; glutathione, ascorbate and ~-tocopherol [11-13]. 
We have previously found that the spontaneous reaction of 
peroxynitrite with proteins results in the nitration of the ortho 
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positions of tyrosine residues to form nitrotyrosine [14]. The 
peroxynitrite-mediated nitration of tyrosine residues can also 
be catalyzed by Fe3*-EDTA and Cu,Zn superoxide dismutase 
[15]. Nitrotyrosine has been detected in human pathologies 
[6-9] and is a useful marker for peroxynitrite detection. Here 
we examined additional protein modifications induced by per- 
oxynitrite. We found that peroxynitrite induced the formation 
of protein carbonyls, the oxidation of tryptophan, tyrosine and 
cysteine residues and to cause protein fragmentation. 
2. Materials and methods 
2.1. Exposure of proteins to peroxynitrite 
Peroxynitrite was synthesized from nitrite and H202 as described 
previously [1]. The concentration fperoxynitrite was measured by the 
increase in absorbance at 302 nm (E302 nm = 1,670 M -~' cm -~) in 1.2 N 
NaOH. Fatty acid free bovine serum albumin (BSA, Boehringer- 
Manheim, Indianapolis, IN) at concentration of 4 mg/ml was reacted 
with chemically synthesized peroxynitrite in 100 mM potassium phos- 
phate buffer, 100 pM diethylenepentaacetic acid(DTPA), pH 7.4. The 
reaction was performed by placing a small aliquot of peroxynitrite (4~8 
pl) in the side of a tube containing the BSA solution immediately 
followed by vigorous vortexing. To control for the potential effect of 
nitrite, nitrate and H202 which are present in peroxynitrite [1], per- 
oxynitrite was allowed to decompose for 5 min in the phosphate buffer 
before the addition of BSA (= 'reverse order'). To insure that peroxyni- 
trite was decomposed, we measured the absorbance of peroxynitrite in
100 mM potassium phosphate buffer, 100 pM DTPA, pH 7.4 at 302 
nm. The absorbance at 302 nm of the decomposed peroxynitrite was 
the same as the buffer alone. 
2.2. Lung perfusion 
We utilized a blood-free isolated lung preparation [16]. All animal 
studies in this work have been approved by the Institutional Animal 
Care and Use Committee. Sprague-Dawley, adult, male rats (Charles 
River Breeding Laboratories, Kingston, NY) weighing 150-170 g were 
anesthetized and a tracheostomy was performed. The lungs were iso- 
lated and ventilated continuously with 95% oxygen/5% carbon dioxide 
throughout the duration of the experiments. The lungs were perfused 
at constant flow rate of 12 ml/min with a recirculating Krebs-Ringer 
bicarbonate buffer, pH = 7.4 containing 3% (w/v) fatty acid free-BSA 
and 10 mM glucose that was maintained at 37°C and equilibrated with 
the same gas mixture as the ventilation gas, Lungs were made ischemic 
by stopping the flow for 2 h while maintaining ventilation. 
2.3. Analytical methods' 
After completion of the experiment the lungs were rapidly clamped 
frozen in liquid nitrogen• Lungs were homogenized under nitrogen in 
ice cold saline (1:10 tissue/medium) containing 0.01% butylated hy- 
droxytoluene. 2,4 dinitrophenylhydrazine (DNPH)-reactive protein 
carbonyls in lung homogenates were analyzed as described previously 
[16]. To account for the presence of nitrotyrosine in the DNPH-reacted 
samples (DNPH and nitrotyrosine absorb maximally at 358 nm at 
acidic pH), all samples were divided to two aliquots that contained 
equal amount of protein. One aliquot was reacted with 0.05% (wt./vol.) 
DNPH (Aldrich, Milwaukee, WI) in 1 M HC1 and the other with IM 
HC1 for one hour at 37°C. At the end of the incubation, the samples 
were passed through a Sephadex G-25 column using 50 mM phosphate 
buffer pH 6.0. The difference in absorbance at358 nm (DNPH reacted- 
HCI reacted) was used to estimate the concentration of the DNPH- 
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reactive protein carbonyls using 6358 nm = 21,000 M -t "cm ~. The yield 
of nitration was determined by measuring the absorbance at pH 11.5, 
(e430 .m = 4,400 M -1" cm-~). Formation of dityrosine was monitored by 
the absorbance at 330 nm using the e330 nm = 4,000 M -l 'cm -~. Oxida- 
tion of tryptophan was followed by the changes in fluorescence ( xcita- 
tion 2 = 325 nm and emission 2 = 410 nm). The fatty acid free BSA 
samples were analyzed on 10% SDS gels and silver stained following 
the completion of the analysis. For amino acid analysis fatty acid 
free-BSA was reacted with peroxynitrite as described above and then 
hydrolyzed in vapor phase with 6 N HC1 containing 1% phenol for 24 
h at 110°C. The hydrolyzed samples were derivatized at room temper- 
ature with phenylisothiocyanate (PTC) and the derivitized amino acids 
were separated on a reverse phase Waters PicoTag column (3.9 x 150 
mm). The PTC-amino acids in the hydrolysates were quantified by 
comparing their retention times and peak areas with a freshly derivi- 
tized standard mixture of amino acids containing authentic nitroty- 
rosine (Aldrich, Milwaukee, WI). 
3. Results and discussion 
Fatty acid free-BSA reacted with the same volume of differ- 
ent peroxynitrite concentrations in order to achieve an 10:1, 
1:1, 1:5 and l :10 ratio of protein to peroxynitrite. 
We used a solution of 60.6 pM BSA in 100 mM potassium 
phosphate buffer to control for changes in pH because the 
chemically synthesized peroxynitrite is stored in 1.2 M NaOH. 
Since peroxynitrite decomposes in phosphate buffer with a 
pseudo first order rate of 1.3 s -~ at 25°C and pH 7.4, a concen- 
tration of 606 pM peroxynitrite - to give a ratio of 1 : 10 will 
correspond approximately to a steady state exposure of 8.5/.tM 
for 1 min. Figure 1 shows that a molar ratio of 10:1 did not 
result in formation of protein carbonyls. However, reacting the 
protein at ratio of l : 1 or greater resulted in a concentration 
dependent increase of protein carbonyls. Similarly increasing 
the concentration of peroxynitrite to a molar ratio of I : 1, 1 : 5 
and 1:10 resulted in the oxidation of 41, 74 and 77% (n = 3) of 
the single free cysteine residue, respectively. The oxidation of 
the cysteine residue by peroxynitrite to form a protein-thiyl 
radical has been recently reported [17]. 
The reaction of protein with peroxynitrite resulted in a de- 
crease oftryptophan fluorescence (Fig. 2A). The maximal tryp- 
tophan fluorescence of the unreacted protein was taken to 
represent 121.2/.tM because BSA contains two tryptophan res- 
idues. A 12, 29 and 45% oxidation of tryptophan residues was 
observed following the reaction of BSA with 1 : l, 1:5 and 1 : l0 
ratio of protein to peroxynitrite, respectively. The fluorescence 
10.0~ 
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Reverse order 
Ratio of protein:peroxynitrite [~M] 
Fig. 1. DNPH-reactive carbonyl formation following treatment with 
peroxynitrite. Unreacted protein contained 2.1 _+ 0.4 nmol/mg protein. 
The results represent 3 different preparation of fatty acid free-BSA and 
are expressed as mean _+ S.D.*P < 0.05 compared to unreacted and 
reverse order of addition. 
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Fig. 2. Peroxynitrite-mediated modification of aromatic acid residues. 
(A) Loss of tryptophan fluorescence. (B) Formation of 3-nitrotyrosine. 
(C) Formation of dityrosine. Results represent 3 6 different prepara- 
tion of fatty acid free-BSA and are expressed as mean _+ S.D. 
of tryptophan is dependent on the integrity of the indole ring. 
Disruption of the ring by oxidation or N-nitration may be 
responsible for the loss of fluorescence. If N-nitration of the 
indole ring occurs then this may be another specific modifica- 
tion mediated by peroxynitrite that will be useful for in vivo 
detection. BSA contains 19 tyrosine residues and 1 : 1, 1 : 5 and 
1 : 10 ratio of protein to peroxynitrite 0.12, 1.4 and 3.2% of the 
tyrosine residues were nitrated (Fig. 2B). The nitration of tyro- 
sine residues was also confirmed by amino acid analysis. Based 
on the absorbance at 430 nm at alkaline pH the yield of nitro- 
tyrosine of the peroxynitrite-treated BSA samples at 1 : 10 ratio 
was 8.4 + 0.5 ktg/mg of protein which was the same as the 
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amount of nitrotyrosine detected by amino acid analysis 
9.8 + 1.8/tg/mg (n = 3) of protein. At 1 : 1, 1 : 5 and 1 : 10 ratio 
of protein to peroxynitrite 0.02, 0.09 and 0.11% of tyrosine 
residues were oxidized to dityrosine. The low yield of dityrosine 
formation is also confirmed by the absence of significant pro- 
tein aggregation revealed by SDS-PAGE analysis (Fig. 3). 
However, the reaction of fatty acid free-BSA with peroxynitrite 
resulted in protein fragmentation as shown by the increase in 
band intensity of protein fragments with molecular weight 
lower than 66,000 (Figure 3). Furthermore, amino acid analysis 
of the protein reacted at ratio of 1 : 10 in addition to decrease 
in tyrosine residues also revealed a decreased recovery of more 
than 5%, as compared to control, of glutamic acid, histidine 
threonine and alanine (not shown). Histidine has been found 
to be sensitive to oxidation by reactive oxygen species as well 
as metal ion catalyzed oxidations [18]. Although not detected 
in this model system peroxynitrite has been shown to hydroxyl- 
ate phenylalanine [19] and to oxidize methionine in cd-pro- 
teinase inhibitor [20]. 
Since the reaction of BSA with peroxynitrite resulted in the 
formation of DNPH-reactive protein carbonyls we examined 
the ability of peroxynitrite to form protein carbonyls in a prep- 
aration of lung homogenates. It was shown that ischemic injury 
to the lung results in an increase of protein carbonyls [16]. Lung 
Non - Reduced 
1 2 3 4 
66 kDa D 
Reduced 
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66 kDa Sl~ 
Fig. 3. Silver staining of SDS-PAGE analysis of peroxynitrite-treated 
samples. The same results were reproduced for at least 3 different 
protein preparations analyzing 20 ,ug of protein per lane. Lane: 1, 
reverse order of addition at 1 : 10 molar atio of protein to peroxynitrite; 
2, protein reacted at 1 : 10 molar ratio; 3, protein reacted at 1 : 5 molar 
ratio; 4, unreacted protein; 5, unreacted protein reduced with fl-mercap- 
toethanol; 6, protein reacted at 1 : 5 molar ratio; 7, protein reacted at 
1 : 10 molar ratio; and 8, reverse order of addition at 1 : I0 molar ratio 
of protein to peroxynitrite. 
Table 1 
DNPH-reactive protein carbonyls in lung homogenate 
DNPH-reactive protein carbonyls 
(nmol/mg of protein) 
Control 2 h perfusion 2.2 + 0.1 
2 h Ischemia 6.9 + 0.4* 
10 mM tert-Butyl 
hydroperoxide 
+ 100 JIM Fe 2÷ 7.4 + 0.5* 
300 tiM peroxynitrite 11.2 + 0.7*'** 
Isolated rat lungs were perfused or made ischemic as described in 
methods. Lung homogenate aliquots containing 4-5 mg protein/ml 
were reacted with 10 rnM tert-Butyl hydroperoxide plus 100/.tM Fe +2 
for 30 min at 37°C and with peroxynitrite atroom temperature. Data 
of three different lung homogenates is expressed as mean + SD, *differ- 
ent than control, **different than 10 mM tert-butyl hydroperoxide plus 
100 ,uM Fe 2+. 
homogenates containing approximately 4 mg/ml protein were 
reacted with 300 ¢tM peroxynitrite. This treatment resulted in 
the formation of 11.2 + 0.7 nmol/mg of protein DNPH-reactive 
carbonyls that was significantly higher than control and than 
the levels of carbonyls formed after treatment of the same lung 
homogenates with 10 mM tert-butyl hydroperoxide in the pres- 
ence of 100 ¢tM ferrous iron for 30 rain at 37°C (Table 1). The 
levels of DNPH-reactive carbonyls formed by 300 ¢tM per- 
oxynitrite which corresponds to an exposure of 4 mM for 1 min 
were also higher than the levels measured after 2 h of ischemia 
suggesting that peroxynitrite can contribute to in vivo protein 
carbonyl formation. Furthermore, we have recently found that 
the levels of protein carbonyls in ischemic rat lungs are signif- 
icantly reduced by blockade of nitric oxide production [21]. 
Overall, peroxynitrite induced an array of protein modifica- 
tions that arranged in order of magnitude include; cysteine 
oxidation, tryptophan oxidation, tyrosine nitration, formation 
of protein carbonyls, formation of dityrosine and protein frag- 
mentation. The nitration of tyrosine residues and possibly of 
tryptophan are useful markers for detecting peroxynitrite in 
biological samples. Although the protein induced modifications 
of BSA by peroxynitrite can be considered to contribute to the 
antioxidant action of albumin in extracellular fluids [17], nitra- 
tion of tyrosine residues and other peroxynitrite-mediated mod- 
ifications inactivate important proteins uch as Mn superoxide 
dismutase [14], surfactant protein A [22] and ~-1 proteinase 
inhibitor [20] and may contribute to toxicity in human disor- 
ders. 
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